SUGAR LAND, TX -- (MARKET WIRE) -- March 27, 2007 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas). The tough times have continued into 2007 for the Pharmaceutical-Biotech Industry, especially in terms of plant closures and cutbacks. Nevertheless, some light has appeared at the end of a very dark tunnel as indicated by a recent survey of the top ten reported Pharma-Bio projects scheduled to begin construction this year. Cumulatively, these projects represent a total capital investment of $2.02 billion, which averages out to a healthy $200 million each. >>> Discuss This Story
